Itopride is a new type of prokinetic agent, that acts both as a dopamine D2 receptor antagonist and as an acetylcholine esterase inhibitor.
It accelerates gastric emptying, improves gastric tension and sensitivity, and has an anti-emetic action.
Good efficacy in terms of global patients assessment, postprandial fullness, and early satiety in the treatment of patients with Functional dyspepsia and shows a low rate of adverse reactions.
Superior in efficacy and safety over mosapride citrate in the management of functional dyspepsia.